384 related articles for article (PubMed ID: 32615135)
1. The CX3CL1/CX3CR1 axis is upregulated in chronic kidney disease and contributes to angiotensin II-induced migration of vascular smooth muscle cells.
Li C; Zhong X; Xia W; He J; Gan H; Zhao H; Xia Y
Microvasc Res; 2020 Nov; 132():104037. PubMed ID: 32615135
[TBL] [Abstract][Full Text] [Related]
2. CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Inflammatory Cytokine Production.
Li C; He J; Zhong X; Gan H; Xia Y
Inflammation; 2018 Jun; 41(3):824-834. PubMed ID: 29356931
[TBL] [Abstract][Full Text] [Related]
3. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
4. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
Cormican S; Griffin MD
Front Immunol; 2021; 12():664202. PubMed ID: 34163473
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
7. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
Dong X; Yu LG; Sun R; Cheng YN; Cao H; Yang KM; Dong YN; Wu Y; Guo XL
J Cell Biochem; 2013 Jan; 114(1):174-82. PubMed ID: 22887358
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
11. Pentamethylquercetin attenuates angiotensin II-induced abdominal aortic aneurysm formation by blocking nuclear translocation of C/EBPβ at Lys253.
Wu H; Wang J; Bu Y; Li J; Li Y; Jing Q; Wang X; Yan C; Liu D; Han Y
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167224. PubMed ID: 38723872
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced overexpression of sirtuin 1 contributes to enhanced expression of Giα proteins and hyperproliferation of vascular smooth muscle cells.
Hossain E; Li Y; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H496-H508. PubMed ID: 34270373
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
15. Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
Zhang P; Wang BJ; Wang JZ; Xie XM; Tong QX
Curr Med Sci; 2020 Dec; 40(6):1121-1127. PubMed ID: 33428140
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
17. The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice.
Yu YW; Li MX; Zhang ZY; Yu H
Int J Mol Med; 2018 Jun; 41(6):3577-3585. PubMed ID: 29568873
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
19. Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II.
Nakashima H; Frank GD; Shirai H; Hinoki A; Higuchi S; Ohtsu H; Eguchi K; Sanjay A; Reyland ME; Dempsey PJ; Inagami T; Eguchi S
Hypertension; 2008 Feb; 51(2):232-8. PubMed ID: 18180404
[TBL] [Abstract][Full Text] [Related]
20. CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.
Tsai MH; Lee CW; Hsu LF; Li SY; Chiang YC; Lee MH; Chen CH; Liang HF; How JM; Chang PJ; Wu CM; Lee IT
Redox Biol; 2017 Aug; 12():377-388. PubMed ID: 28292711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
